STAVUDINE Side Effects

6925247-1 | Diplopia, Eyelid Ptosis, Lipodystrophy Acquired, Mitochondrial Toxicity, Progressive External Ophthalmoplegia
on Aug 05, 2010 Male patient from UNITED STATES , 52 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia, eyelid ptosis, lipodystrophy acquired, mitochondrial toxicity, progressive external ophthalmoplegia. Stavudine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), NORVIR (View Norvir Review and Norvir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ).

6922230-7 | Uveitis
Patient was taking Stavudine (View Usage). Patient had the following side effects: uveitis on Jul 29, 2010 from TURKEY Additional patient health information: Female patient , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).

6913308-2 | Uveitis
Adverse event was reported on Aug 02, 2010 by a Female patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: TURKEY , 36 years of age, After Stavudine was administered, patient had the following side effects: uveitis. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).

6835385-X | Uveitis
on Jun 29, 2010 Female patient from TURKEY , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: uveitis. Stavudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).


6801664-5 | Withdrawal Syndrome
on Jun 21, 2010 Male patient from MALAYSIA , 52 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient had the following side effects: withdrawal syndrome. Stavudine dosage: . During the same period patient was treated with METHADONE (Increased To 60mg/day After 4 Weeks Subsequently 400mg) (View Methadone Review and Methadone Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).

6744511-2 | Progressive Multifocal Leukoencephalopathy
Patient was taking Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: progressive multifocal leukoencephalopathy on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , 30 years of age, . Stavudine dosage: . During the same period patient was treated with ABACAVIR (View Abacavir Review and Abacavir Label ), AMPRENAVIR (View Amprenavir Review and Amprenavir Label ).

6744510-0 | Progressive Multifocal Leukoencephalopathy
Adverse event was reported on May 17, 2010 by a Male patient taking Stavudine (View Usage) (Dosage: ) . Location: UNITED STATES , 35 years of age, Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy. During the same period patient was treated with NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6744503-3 | Progressive Multifocal Leukoencephalopathy
on May 17, 2010 Female patient from UNITED STATES , 52 years of age, was treated with Stavudine (View Usage). Patient had the following side effects: progressive multifocal leukoencephalopathy. Stavudine dosage: . During the same period patient was treated with NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ).

6744478-7 | Progressive Multifocal Leukoencephalopathy
on May 17, 2010 Male patient from UNITED STATES , 36 years of age, was treated with Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: progressive multifocal leukoencephalopathy. Stavudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6738075-7 | Abdominal Distension, Dyslipidaemia, Fat Tissue Increased, Hyperhidrosis, Lipodystrophy Acquired, Myocardial Infarction, Neutropenia, Palpitations, Sinus Tachycardia
Patient was taking Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, dyslipidaemia, fat tissue increased, hyperhidrosis, lipodystrophy acquired, myocardial infarction, neutropenia, palpitations, sinus tachycardia on May 03, 2010 from PORTUGAL Additional patient health information: Female patient , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6731067-3 | Diplopia, Eyelid Ptosis, Lipodystrophy Acquired, Mitochondrial Toxicity, Progressive External Ophthalmoplegia
Adverse event was reported on May 04, 2010 by a Male patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: diplopia, eyelid ptosis, lipodystrophy acquired, mitochondrial toxicity, progressive external ophthalmoplegia. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ).

6709868-7 | Guillain-barre Syndrome, Metabolic Acidosis, Pancreatitis
on Apr 29, 2010 Female patient from UNITED STATES , 54 years of age, weighting 229.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?), metabolic acidosis, pancreatitis. Stavudine dosage: . During the same period patient was treated with MARAVIROC (View Maraviroc Review and Maraviroc Label ), KALETRA (View Kaletra Review and Kaletra Label ), LAMIVUDINE (Also Taken On 17oct2007) (View Lamivudine Review and Lamivudine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.

6701416-0 | Osteonecrosis
on Apr 15, 2010 Male patient from COTE D'IVOIRE , 44 years of age, weighting 149.9 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Stavudine dosage: Unk. During the same period patient was treated with LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (Unk) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ), DIDANOSINE (Unk) (View Didanosine Review and Didanosine Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), LOPINAVIR AND RITONAVIR (Unk) (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ). Patient was hospitalized.

6701414-7 | Osteonecrosis
Patient was taking Stavudine (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Apr 15, 2010 from COTE D'IVOIRE Additional patient health information: Male patient , 45 years of age, weighting 145.5 lb, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: Unk. During the same period patient was treated with DIDANOSINE (Unk) (View Didanosine Review and Didanosine Label ), NELFINAVIR MESYLATE (Unk) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ), ABACAVIR SULFATE (Unk) (View Abacavir Sulfate Review and Abacavir Sulfate Label ). Patient was hospitalized.

6662175-3 | Neuropathy Peripheral, Osteonecrosis
Adverse event was reported on Mar 17, 2010 by a Male patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: COTE D'IVOIRE , 45 years of age, weighting 145.5 lb, After Stavudine was administered, patient had the following side effects: neuropathy peripheral, osteonecrosis (What is osteonecrosis?). During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), KALETRA /01506501/ (View Kaletra /01506501/ Review and Kaletra /01506501/ Label ). Patient was hospitalized.

6662174-1 | Neuropathy Peripheral, Osteonecrosis
on Mar 17, 2010 Male patient from COTE D'IVOIRE , 45 years of age, weighting 145.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral, osteonecrosis (What is osteonecrosis?). Stavudine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), KALETRA /01506501/ (View Kaletra /01506501/ Review and Kaletra /01506501/ Label ). Patient was hospitalized.

6662172-8 | Osteonecrosis
on Mar 17, 2010 Male patient from COTE D'IVOIRE , 44 years of age, weighting 149.9 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Stavudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), KALETRA /01506501/ (View Kaletra /01506501/ Review and Kaletra /01506501/ Label ). Patient was hospitalized.

6662170-4 | Osteonecrosis
Patient was taking Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Mar 17, 2010 from COTE D'IVOIRE Additional patient health information: Male patient , 44 years of age, weighting 149.9 lb, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), KALETRA /01506501/ (View Kaletra /01506501/ Review and Kaletra /01506501/ Label ). Patient was hospitalized.

6653257-0 | Hypertriglyceridaemia, Lipodystrophy Acquired, Neuropathy Peripheral, Osteonecrosis
Adverse event was reported on Mar 15, 2010 by a Male patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: COTE D'IVOIRE , 45 years of age, weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: hypertriglyceridaemia, lipodystrophy acquired, neuropathy peripheral, osteonecrosis (What is osteonecrosis?). During the same period patient was treated with DIDANOSINE (Also Given In Jul-2001, Jul-2002) (View Didanosine Review and Didanosine Label ), LAMIVUDINE (Also Given From Jan-2002 And From Mar-2003) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (Also Given In Jul-2001) (View Nelfinavir Review and Nelfinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ). Patient was hospitalized.

6653252-1 | Hypertriglyceridaemia, Osteonecrosis, Virologic Failure
on Mar 15, 2010 Male patient from COTE D'IVOIRE , 44 years of age, weighting 149.9 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient had the following side effects: hypertriglyceridaemia, osteonecrosis (What is osteonecrosis?), virologic failure. Stavudine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), LAMIVUDINE (Also Given From Feb-2004) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ). Patient was hospitalized.

6652686-9 | Osteonecrosis
on Mar 12, 2010 Male patient from COTE D'IVOIRE , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). Stavudine dosage: Unk. During the same period patient was treated with DIDANOSINE (Unk) (View Didanosine Review and Didanosine Label ), NELFINAVIR (Unk) (View Nelfinavir Review and Nelfinavir Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ), ABACAVIR SULFATE (Unk) (View Abacavir Sulfate Review and Abacavir Sulfate Label ), LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6652682-1 | Osteonecrosis
Patient was taking Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?) on Mar 12, 2010 from COTE D'IVOIRE Additional patient health information: Male patient , 44 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: Unk. During the same period patient was treated with LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (Unk) (View Nelfinavir Review and Nelfinavir Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ), DIDANOSINE (Unk) (View Didanosine Review and Didanosine Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), INDINAVIR/RITONAVIR (View Indinavir/ritonavir Review and Indinavir/ritonavir Label ). Patient was hospitalized.

6614247-7 | Lipodystrophy Acquired, Mitochondrial Toxicity, Progressive External Ophthalmoplegia
Adverse event was reported on Feb 19, 2010 by a Male patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: lipodystrophy acquired, mitochondrial toxicity, progressive external ophthalmoplegia. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ).

6587975-X | Bone Marrow Failure, Gastric Ulcer Haemorrhage, Nausea, Pneumocystis Jiroveci Pneumonia, Renal Failure Acute, Respiratory Failure, Seminoma
on Feb 09, 2010 Male patient from JAPAN , 48 years of age, was diagnosed with acquired immunodeficiency syndrome, prophylaxis, seminoma and was treated with Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: bone marrow failure, gastric ulcer haemorrhage, nausea (What is nausea?), pneumocystis jiroveci pneumonia, renal failure acute, respiratory failure, seminoma. Stavudine dosage: . During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), CISPLATIN (On Days 1 To 5, Continuous Infusion) (View Cisplatin Review and Cisplatin Label ), BLEOMYCIN HCL (1 Dosageform = 30mg/body Form = Inj On Days 2, 9, 16) (View Bleomycin Hcl Review and Bleomycin Hcl Label ), ETOPOSIDE (On Days 1-5) (View Etoposide Review and Etoposide Label ), LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), LAMIVUDINE (Form = Tabs) (View Lamivudine Review and Lamivudine Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6583710-X | Abdominal Pain, Coagulopathy, Jaundice, Malaise, Mental Status Changes, Nausea, Pancreatitis, Pyrexia
on Feb 13, 2010 Male patient from UNITED STATES , 37 years of age, weighting 198.4 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), coagulopathy, jaundice (What is jaundice?), malaise, mental status changes, nausea (What is nausea?), pancreatitis, pyrexia. Stavudine dosage: Oral 047.

6567647-8 | Cholangitis, Cholestasis, Convulsion, Cytomegalovirus Viraemia, Hepatitis, Hepatotoxicity, Oesophageal Candidiasis, Respiratory Failure
Patient was taking Stavudine (View Usage). Patient had the following side effects: cholangitis, cholestasis, convulsion, cytomegalovirus viraemia, hepatitis (What is hepatitis?), hepatotoxicity, oesophageal candidiasis, respiratory failure on Jan 25, 2010 from GERMANY Additional patient health information: Male patient , 24 years of age, was diagnosed with pneumocystis jiroveci pneumonia and. Stavudine dosage: . During the same period patient was treated with CO TRIMOXAZOLE (1 Dosageform = 20mg Trimethoprim Per Kg) (View Co-trimoxazole Review and Co-trimoxazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).

6528027-4 | Angina Unstable, Myocardial Ischaemia
Adverse event was reported on Dec 23, 2009 by a Male patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 52 years of age, weighting 160.9 lb, After Stavudine was administered, patient had the following side effects: angina unstable, myocardial ischaemia. During the same period patient was treated with MARAVIROC (View Maraviroc Review and Maraviroc Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

6502739-0 | Diabetes Mellitus, Hyperlactacidaemia, Hyperlipidaemia, Lipoatrophy, Neuropathy Peripheral
on Dec 07, 2009 Female patient from MALAWI , 58 years of age, weighting 74.96 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, hyperlactacidaemia, hyperlipidaemia, lipoatrophy, neuropathy peripheral. Stavudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).

6465655-9 | Blood Pressure Decreased, Cardiomegaly, Granuloma, Heart Rate Increased, Immune Reconstitution Syndrome, Lymphadenopathy, Necrosis, Pericarditis, Ventricular Hypokinesia
on Nov 09, 2009 Female patient from , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient had the following side effects: blood pressure decreased, cardiomegaly, granuloma, heart rate increased, immune reconstitution syndrome, lymphadenopathy, necrosis, pericarditis, ventricular hypokinesia. Stavudine dosage: 60mg, Daily,. During the same period patient was treated with EFAVIRENZ (600mg, Daily,) (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (300mg - Daily -) (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6465645-6 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Hepatomegaly, Immune Reconstitution Syndrome, Lymph Node Tuberculosis
Patient was taking Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, hepatomegaly, immune reconstitution syndrome, lymph node tuberculosis on Nov 09, 2009 from Additional patient health information: Female patient , 38 years of age, was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?) and. Stavudine dosage: 60mg - Daily. During the same period patient was treated with LAMIVUDINE (300mg - Daily) (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (600mg - Daily) (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6452990-3 | Coronary Artery Occlusion, Dyslipidaemia, Lipodystrophy Acquired, Myocardial Infarction, Neutropenia, Sinus Tachycardia
Adverse event was reported on Nov 02, 2009 by a Male patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: PORTUGAL , 34 years of age, Patient experienced the following unwanted or unexpected effects: coronary artery occlusion, dyslipidaemia, lipodystrophy acquired, myocardial infarction, neutropenia, sinus tachycardia. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ). Patient was hospitalized.

6405071-9 | Agitation, Anxiety, Confusional State, Delirium, Depression, Emotional Distress, Hallucination, Poor Quality Sleep, Refusal Of Treatment By Patient
on Sep 23, 2009 Female patient from SOUTH AFRICA , child 9 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient had the following side effects: agitation, anxiety (What is anxiety?), confusional state, delirium, depression (What is depression?), emotional distress, hallucination, poor quality sleep, refusal of treatment by patient. Stavudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6405017-3 | Delirium, Depression, Hemiplegia, Intracranial Pressure Increased, Meningitis Tuberculous
on Sep 23, 2009 Female patient from SOUTH AFRICA , child 11 years of age, was diagnosed with hiv infection (What is hiv infection?), pulmonary tuberculosis and was treated with Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: delirium, depression (What is depression?), hemiplegia, intracranial pressure increased, meningitis tuberculous. Stavudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHIONAMIDE (View Ethionamide Review and Ethionamide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6396324-1 | Delirium, Serotonin Syndrome
Patient was taking Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: delirium, serotonin syndrome on Sep 30, 2009 from SOUTH AFRICA Additional patient health information: Female patient , child 9 years of age, weighting 57.32 lb, was diagnosed with hiv infection (What is hiv infection?), depression (What is depression?), tuberculosis (What is tuberculosis?) and. Stavudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), FLUOXETINE (5 Mg, Qd) (View Fluoxetine Review and Fluoxetine Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHIONAMIDE (View Ethionamide Review and Ethionamide Label ). Patient was hospitalized.

6382057-4 | Delirium, Serotonin Syndrome
Adverse event was reported on Sep 21, 2009 by a Female patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: SOUTH AFRICA , child 9 years of age, weighting 57.32 lb, Patient had the following side effects: delirium, serotonin syndrome. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6376495-3 | Agitation, Catatonia, Delirium, Delusion, Euphoric Mood, Fear, Hallucination, Hypervigilance
on Sep 14, 2009 Female patient from SOUTH AFRICA , child 9 years of age, was diagnosed with hiv infection (What is hiv infection?), depression (What is depression?) and was treated with Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: agitation, catatonia, delirium, delusion, euphoric mood, fear, hallucination, hypervigilance. Stavudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), FLUOXETINE (5 Mg, Qd) (View Fluoxetine Review and Fluoxetine Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHIONAMIDE (View Ethionamide Review and Ethionamide Label ). Patient was hospitalized.

6367317-5 | Kaposi's Sarcoma, Pleural Effusion
on Sep 15, 2009 Male patient from JAPAN , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: kaposi's sarcoma (What is kaposi's sarcoma?), pleural effusion. Stavudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ). Patient was hospitalized.

6359378-4 | Lipodystrophy Acquired, Progressive External Ophthalmoplegia
Patient was taking Stavudine (View Usage). Patient had the following side effects: lipodystrophy acquired, progressive external ophthalmoplegia on Sep 14, 2009 from CANADA Additional patient health information: Male patient , 52 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ).

6359377-2 | Lipodystrophy Acquired, Progressive External Ophthalmoplegia
Adverse event was reported on Sep 14, 2009 by a Male patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: CANADA , 54 years of age, After Stavudine was administered, patient had the following side effects: lipodystrophy acquired, progressive external ophthalmoplegia. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ).

6359339-5 | Lipodystrophy Acquired, Progressive External Ophthalmoplegia
on Sep 14, 2009 Male patient from CANADA , 58 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: lipodystrophy acquired, progressive external ophthalmoplegia. Stavudine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6347263-3 | Lipoatrophy, Mitochondrial Cytopathy, Neoplasm Progression
on Sep 02, 2009 Male patient from AUSTRALIA , 49 years of age, was treated with Stavudine (View Usage). Patient had the following side effects: lipoatrophy, mitochondrial cytopathy, neoplasm progression. Stavudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (1 Df = 500 (units Not Specified).) (View Zidovudine Review and Zidovudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ).

6344837-0 | Hepatic Failure, Lactic Acidosis, Tachypnoea
Patient was taking Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: hepatic failure, lactic acidosis, tachypnoea on Aug 24, 2009 from UNITED STATES Additional patient health information: Female patient , 32 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: .

6337704-X | Hepatic Failure, Lactic Acidosis, Pregnancy
Adverse event was reported on Aug 26, 2009 by a Female patient taking Stavudine (View Usage) (Dosage: ) . Location: SOUTH AFRICA , 32 years of age, Patient experienced the following unwanted or unexpected effects: hepatic failure, lactic acidosis, pregnancy (What is pregnancy?). During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6324106-5 | Brachial Plexus Injury, Erb's Palsy, Large For Dates Baby, Paralysis Flaccid, Vacuum Extractor Delivery
on Aug 11, 2009 Male patient from , weighting 8.42 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient had the following side effects: brachial plexus injury, erb's palsy, large for dates baby, paralysis flaccid, vacuum extractor delivery. Stavudine dosage: 60 Mg, Daily, Transplacent. During the same period patient was treated with LAMIVUDINE (300mg Daily, Transplacen) (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (600 Mg Daily; Transplacentally) (View Efavirenz Review and Efavirenz Label ).

6321787-7 | Disease Complication, Hepatic Failure, Lactic Acidosis, Pregnancy, Tachypnoea
on Aug 17, 2009 Female patient from SOUTH AFRICA , 32 years of age, was treated with Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: disease complication, hepatic failure, lactic acidosis, pregnancy (What is pregnancy?), tachypnoea. Stavudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6313717-9 | Normal Newborn, Pre-eclampsia
Patient was taking Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: normal newborn, pre-eclampsia on Jun 28, 1999 from UNITED STATES Additional patient health information: Female patient , 32 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: . During the same period patient was treated with NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6297712-4 | Abortion Spontaneous
Adverse event was reported on Jul 30, 2009 by a Female patient taking Stavudine (View Usage) (Dosage: ) was diagnosed with hepatitis b virus test and. Location: SOUTH AFRICA , 31 years of age, Patient had the following side effects: abortion spontaneous. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).

6289429-7 | Encephalitis
on Jul 24, 2009 Male patient from UNITED STATES , 39 years of age, was diagnosed with hiv infection (What is hiv infection?), hepatitis c (What is hepatitis c?) and was treated with Stavudine (View Usage). After Stavudine was administered, patient had the following side effects: encephalitis (What is encephalitis?). Stavudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ). Patient was hospitalized.

6287940-6 | Acute Myeloid Leukaemia
on Jul 22, 2009 Male patient from SPAIN , 54 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Stavudine (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia. Stavudine dosage: . During the same period patient was treated with INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6276151-6 | Hyperlactacidaemia
Patient was taking Stavudine (View Usage). Patient had the following side effects: hyperlactacidaemia on Jul 15, 2009 from UGANDA Additional patient health information: Female patient , 60 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Stavudine dosage: 30 Mg, Unk. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).